tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with guanethidine in 1 studies
Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (guanethidine) | Trials (guanethidine) | Recent Studies (post-2010) (guanethidine) |
---|---|---|---|---|---|
74 | 0 | 17 | 3,803 | 117 | 55 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lishmanov, IuB; Maslov, LN; Naryzhnaia, NV; Revinskaia, IuG | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and guanethidine
Article | Year |
---|---|
[The role of peripheral and central mu-opiate receptors in the modulation of adrenergic cardiac lesions during stress].
Topics: Adrenal Glands; Adrenergic Agents; Animals; Brain; Cardiomyopathies; Catecholamines; Diphosphates; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Guanethidine; Injections, Intraventricular; Male; Myocardium; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, mu; Stress, Physiological; Sympathetic Nervous System | 1998 |